7/25/2019 Syok DepKes AP
1/20
7/25/2019 Syok DepKes AP
2/20
!"#$ &'(&')*$+,-# .'+')/$)$) /'+-$0$& "12.
!"#$ %&'()'*"# ,$*-)*. /$"$0 1'*#*.($-$* 234
3'4$"$ 56 768
7 9$-,) 766 786
:$1# :$+, ;$-#+ 7
7/25/2019 Syok DepKes AP
3/20
9'.$)$)3$+$-
>,+$-
?$)/,)*
@'"#"/')"#A$".,B$+
C#"/'(#.
D"# C'.,)E,&
3')1,/ ?$)/,)*!"#$%&'()
F2)/+$./#B#/$"
*%$&'()
7/25/2019 Syok DepKes AP
4/20
D)0'." "12.
G+'.,')"# ?$)/,)*
H$./, &')*#"#$) .$B'+
9'.$)$) 3$+$-
3$(&$. .'-#B$)*$) E$#+$) #)/+$I$".,B$+
J=6 (;K.* J
7/25/2019 Syok DepKes AP
5/20
9$.#.$+0#
M$0# B'($-
N#&2/')"#
O'+P,"# Q$+#)*$) R,+,.
H$./, &')*#"#$) .$B'+ S = 0'/#.
F'"$0$+$) ('),+,)O+20,."# ,+#)' ('),+,)
TUV:U@UM F;DMDC CWXF OY3DU9@DF
A. Pudjia!
7/25/2019 Syok DepKes AP
6/20
JAMA. 1991;266:1242-1245
Based on our findings, repeated 20-mL/kg fluidboluses may be administered in excess of 60 mL/kg
in the first hour, and 120 mL/kg in the first 6 hours ifblood pressure, peripheral pulses, mental status,
arterial blood gas levels, urine output, and peripheral
color suggest that perfusion remains decreased.
7/25/2019 Syok DepKes AP
7/20
JO+JM$JO+JM$JO+JM$
M$J>B
U :
7/25/2019 Syok DepKes AP
8/20
LahirDewasa
Cairan Tubuh Total
Cairan Intrasel
Cairan EkstraselBeratb
adan(%)
Friis Hansen 1961
7/25/2019 Syok DepKes AP
9/20
M$>B 6Z[\7L6 (;
8\ UBR,(#)7L6 (;
]Z= ;7Z= ; 6Z< ;
]Z= ;7Z]= ; 6Z$#+$)D)/+$"'B
>$#+$)D)/'+"/#/#$B
YP'. M$>B 6Z[\ 0$) UBR,(#) 8\ &$0$ $)$. ,"#$ 7 /$-,) 0')*$) R'+$/ ^ .*
7/25/2019 Syok DepKes AP
10/20
Deroy, Current Anaesthesia and Critical Care (2000) 11, 2026
Characteristic of Colloids
7/25/2019 Syok DepKes AP
11/20
G+'.,')"# Q$)/,)* )2+($BZ "'",$# ,"#$
F,$B#/$" )$0# R$#.Z /#0$. $0$ &'+R'0$$) &'+#P'+ 0$) "')/+$B
U.+$B -$)*$/
H$./, &')*#"#$) .$B'+ _ = 0'/#.
F'"$0$+$) R$#.
O+20,."# ,+#)' S 7 (BK.*KQ$(
9'.$)$) 0$+$- )2+($BZ "'",$# ,"#$
5$&.'- 67$0A. Pudjia!
7/25/2019 Syok DepKes AP
12/20
:UTUDVUMU VYMD;UD 9Y@;U;! :UMWUF >UD@UM`
O'(R'"$+$) -$/#
@2).-# R$"$- -$B," /#0$. )1$+#)*
!9'.$)$) I')$ Q,*,B$+#"
G2/2 /2+$."
!B/$"2)2*+$a A')$ >$I$ D)P'+#2+
7/25/2019 Syok DepKes AP
13/20
G2/2 92+$." T$*$B ?$)/,)* F2)*'"/#P
8'&$9$- :;+'0#"/+#R,"# I$".,B$+ &$+,
8'&$9$-
7/25/2019 Syok DepKes AP
14/20
!"#$%#&'( *#&+,'"- ./01 234(34,'"
*#56$+,'"-
7,%'"#"-
8'9%'"#"-
:&'"-&;%'"- < 1=> 234(34,'"
?+@#&%-@@#% *#&+,'"- A01 234(34,'"B#%-&'"-&;%'"-
C;-"D9-&;%'"-
:&'"-&;%'"- A 1=> 234(34,'"
?+@#E'9+$#% B'$%#&%6@'E-
B'$%#39DF-%'"-C;-"$#9+,'"-
A. Pudjia!
7/25/2019 Syok DepKes AP
15/20
3X=b7c]LdNRdC$/e6c66]dO$X= TB,.2"$
C#.B," F+'R
.'.,+$)*$) U9O b C12.C12. -#&2."#.C12. #".'(#.C12. $)'(#.
C12. TB#.2&')#.
A. Pudjia!
7/25/2019 Syok DepKes AP
16/20
=LC'&"#"
^D)",a"#')"# +'B$/#P 7^M2+($B
+%,(- */)01()12 3454
D)",a"#')"# U0+')$B &$0$ C'&"#" O'0#$/+#.
8C12. "'&/#. 76C12. "'&/#.
=C12. +'"#"/') .$/'.2B$(#) ]C12. +'"#"/') .$/'.2B$(#)
A. Pudjia!
7/25/2019 Syok DepKes AP
17/20
DO2= Cardiac Outputx Arterial Oxygen Content
Frekuensi Jantung X Stroke Volume Hb X 1,34 X SaO2
PreloadKontraktilitas Afterload
Tranfusi
PerbaikipH, pCO2,temperatur
Perbaiki pernapasan/terapi oksigen
Cairan Inotropik Vasodilator/Vasopressor
7/25/2019 Syok DepKes AP
18/20
5$&.'- 5'&$># 0$*9)-
F$0$+ B$./$/ ('),+,) f$/$, $)#2) *$& ('),+,)g
C$/,+$"# I')$ E$I$ S56\6(%)1(7 18)$9S]c] $)0 _Lc6 ;K(#)K(=0')*$)/'.$)$) &'+P,"# )2+($B "'",$# ,"#$
F$0$+ *,B$ 0$+$- )2+($B 0')*$):&/7';$ 18"/;1'8%(#$;1$)* )2+($B
C'&"#" &'0#$/+#.
7/25/2019 Syok DepKes AP
19/20
V'(R,.$ Q$B
V')*')$B 9$)0$ C12.
) )$&$" 0$) V'($"$)* $."'" I$".,B$+
:'+#.$) E$#+$) + ","#/$"# "$(R#B (')*'I$BF2+'."# -#&2*B#.'(#$
$"# +'"&2) .B#)#"
C12. /'+$/$"#O'($)/$,$) h $/$"#
&')1'R$R "12.
C12. /#0$. /'+$/$"# 0'9#/+$"# 02&$(#)'
;$.,.$) &
)*$) E$#+$) +'","#/$"# $/$, ')'&-+#)'
($)/$,$)
C12. /#0$. /'+$/$"#U0$
')*$) E$#+$) 0$) 02&$(.$- +#"#.2 #)",a"#')"# $0+'
#) $/$, ')'&-+#)' )$B`
U0$ +#"#.2:'+#.$) -#0+2.2+/#"2)
9#0$. $?$)*$) R'+#.$
$ +#"#.2 -#0+2.2+/#"2)
C12. R'B,( /'+$/$"#
6'&) ;(%, ;
7/25/2019 Syok DepKes AP
20/20
C12. -$+," 0#E,+#*$# &$0$ $)$. 0')*$) *$)**,$) &'+P,"#Z /$.#.$+0#$Z.,$B#/$" )$0# B'($- 0$) $/$, -#&2/')"#
C#P$/ .2B2#0 0#&')*$+,-# /'.$)$) 2).2/#. 0$) ('/$R2B#"('
F'B'R#-$) E$#+$) -$+," 0#E,+#*$# R#B$ 0#/'(,.$) &'(R'"$+$) -$/#$.,/Z &')#)*.$/$) ?AOZ /#(R,B)1$ +2).# R$"$-Z $/$, /'+0')*$+)1$#+$($ 0'+$&
T$*$B Q$)/,)* .2)*'"/#P ('(R'+#.$) *$(R$+$) P2/2 /2+$." R'+,&$i+'0#"/+#R,"# I$".,B$+ &$+,Z '0'($ #)/'+"/#/#$B 0$) '0'($ $BI'2B'+"'",$# 0'+$Q$/)1$
D)2/+2. h I$"2$./#P 0#R'+#.$) "'/'B$- +'","#/$"# E$#+$) 1$)* $0'.,$/
D)",a"#')"# $0+')$B 0$&$/ (')*$.#R$/.$) "12. +'"#"/') .$/'.2B$(#)
O#B#-$) E$/-'E2B$(#)' 7'&) ;